Alanna Devlin Ball, LCDR, USN (Ret), and Alexandra Takacs, MSN, RN, both knew from an early age that they wanted to join the military. And while neither of these veterans envisioned cancer as part of their future, they agree that their service experiences helped shape their time at Dana-Farber. Ball, a medically retired Navy lieutenant … Read more
Treatments used for many forms of cancer, as well as certain rare types of cancer that directly affect the ear(s), can affect your hearing. It’s important to understand the possibilities and know what to look for because, in some cases, early action can help. If you are affected by hearing loss, there are also resources … Read more
Cancer has not stopped Bethany Ross and Jeremy Pivor from undertaking numerous adventures, from Pivor’s sailing trips on the high seas to Bethany’s forays into skydiving and outdoor rock climbing. It is also often the catalyst for their actions, such as when both Dana-Farber Brigham Cancer Center patients headed to Washington, D.C. to advocate on … Read more
Alanna Devlin Ball spent 12 years in the U.S. Navy, rising to the rank of lieutenant commander and serving with the elite SEAL Team TWO special operations unit. She was trained to always be ready for action, and worked to do so even when facing a daunting off-the-job challenge: brain cancer. In between radiation sessions … Read more
Langley Perer thought her breast cancer was in the rearview mirror. In 2017, she had received a shocking diagnosis at age 35 of ductal in situ carcinoma (DCIS), the earliest form of breast cancer. “As far as I knew, I had no family history of breast cancer,” she says. DCIS is sometimes referred to as … Read more
Brian Humberd firmly believes in an attitude of gratitude. The biotech recruiter from Melrose, Massachusetts remains eternally grateful to Dana-Farber medical oncologist David Fisher, MD, who not only recommended a life-saving stem cell transplant to treat his central nervous system (CNS) lymphoma, but whose advice enabled Humberd to become a father after his cancer treatments. … Read more
In an era when targeted therapies are often effective against multiple types of cancer, the U.S. Food and Drug Administration’s accelerated approval of a two-drug therapy for solid tumors carrying a specific mutation in the BRAF gene is a prime example of this trend. For patients with glioma brain cancer that harbors the mutation, the … Read more
Results of several phase 3 trials and dozens of other studies led by Dana-Farber researchers were presented online and in person June 3-7 at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting. Some of the research reports presented by Dana-Farber investigators include: Improved progression-free … Read more
Stephan Bunker has learned to be prepared for anything during a half-century protecting others as a soldier, volunteer firefighter, law enforcement official, and director of 911 dispatchers for the state of Maine. So when Bunker was the one facing an emergency — a diagnosis of a brain cancer known as primary central nervous system (CNS) … Read more
Karl Helfrich, PhD, has been a cyclist for 40 years. When he was diagnosed with a slow-growing brain tumor, he thought that might be the end of his hobby. Instead, he was only off the bike for three weeks, and continued to ride the roads near his home in Falmouth, Mass. while undergoing radiation and … Read more
At work on the afternoon of December 27, 2018, Chris Barnett felt his eyes lock momentarily onto the wall. Thinking he was just tired, he stood up to go get a sandwich. The next thing he knew, he couldn’t move and fell straight to the floor, and felt frozen in his own body, “like somebody pulled the … Read more
A compound that sparks an immune system attack on cancer while also lowering tumor cells’ defenses against such an attack is showing promise in its first clinical trial in patients with advanced or metastatic cancers. One of those with the best result is a former U.S. Marine and Afghanistan war veteran, Josh Mahoney. Mahoney, of … Read more
Rachel Slater insists that the hardest part about going to Harvard was getting in — if you don’t count her two bouts with brain cancer. Slater, 22, was a high school senior still waiting to hear back from colleges when she was first diagnosed with oligodendroglioma, a form of brain cancer, in early 2017. She … Read more
Dawn MacKerron realizes it might sound strange to say that getting hit in the eye with a basketball was a blessing. But an accident on the court helped inform treatment for a rare form of lymphoma and participation in a clinical trial at Dana-Farber that set her on a cancer-free path. It all started when … Read more
If you happened to be looking for Alex Epshteyn this past winter, you might have found him on the ski slopes. The Charlestown, Massachusetts resident took up the sport just two years ago and has since been enthusiastically sharpening his skills. “I’m overcoming my fear and making progress, which is a great feeling,” Epshteyn says. … Read more
Three-year-old Emily Smith loves to play doctor. She takes great care of her patient — her father, Eric Smith — by pretending to listen to his heart with her toy stethoscope, just like they do on her favorite TV show, Doc McStuffins. But Emily leaves the care of the “boo-boo” on her father’s head to … Read more
Researchers had every reason to expect that a compound called BKM120 (also known as buparlisib) would stifle glioblastoma brain tumors lacking the protein PTEN. After all, it was known to block the tumor-promoting PI3K protein and could easily pass through the blood-brain barrier — the dense layer of cells that guards entry to the brain … Read more
OK Eason doesn’t mind jokes about his unique first name, especially lately. Healthy and thriving more than 30 months after a massive tumor was found in his brain, Eason takes pleasure in telling people that he is more than just “O.K.” Eason, 69, was diagnosed with a glioblastoma in February 2018. He had surgery immediately, … Read more
In 2018, Suzy Pope was diagnosed with an aggressive form of cancer known as glioblastoma. Typically forming in the brain or spinal cord, glioblastomas tend to have a fairly grim prognosis. But two and a half years after her diagnosis, Pope continues to thrive and make the most of every day. Her exceptional response to … Read more
Steve Kelley is the quintessential glass half-full guy. Still, he realizes his reaction to learning he had an extremely rare cancer known as central nervous system (CNS) lymphoma may seem unusual. A few weeks after his June 2018 diagnosis, Kelley, then 64, gathered his family and friends together. He didn’t want to focus negatively on … Read more